Filippo Alongi - Concepedia

Author

Filippo Alongi

Also Known As

Alongi, Alongi F, Alongi Filippo, Alongi, F, Alongi, Filippo, Berardino De Bari, F Alongi, F. Alongi, FILIPPO ALONGI, Filippo ALONGI

684

Publications

10.4K

Citations

H-Index

Concepts

All Affiliations

Ospedale Sacro Cuore Don Calabria University of Brescia Istituti di Ricovero e Cura a Carattere Scientifico Humanitas University IRCCS Humanitas Research Hospital

About

Filippo Alongi is an author at Ospedale Sacro Cuore Don Calabria specializing in medicine, radiation oncology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	34	87	3.5K
2	Health Sciences	29	55	2.2K
3	Engineering	2	2	90
4	Nursing	1	1	48
5	Biostatistics	1	1	21

Filippo Alongi

168

Publications

6.6K

Citations

H-Index

Page 1

	Year	Citations
Is Stereotactic Body Radiation Therapy an Attractive Option for Unresectable Liver Metastases? A Preliminary Report From a Phase 2 Trial Marta Scorsetti, Stefano Arcangeli, A. Tozzi, International Journal of Radiation OncologyBiologyPhysics Surgical OncologyHepatologyRadiation TherapyMedicineHepatobiliary Tumor	2013	190
Linac-based VMAT radiosurgery for multiple brain lesions: comparison between a conventional multi-isocenter approach and a new dedicated mono-isocenter technique Ruggero Ruggieri, S. Naccarato, Rosario Mazzola, Radiation Oncology	2018	165
Radical radiation therapy for oligometastatic breast cancer: Results of a prospective phase II trial Marco Trovò, Carlo Furlan, Jerry Polesel, Radiotherapy and Oncology Radiation MedicineSurgical OncologyHealth SciencesRadiation TherapyBreast Oncology	2017	163
Volumetric modulated arc therapy with flattening filter free (FFF) beams for stereotactic body radiation therapy (SBRT) in patients with medically inoperable early stage non small cell lung cancer (NSCLC) Pierina Navarria, A.M. Ascolese, Pietro Mancosu, Radiotherapy and Oncology Adaptive RadiotherapyRadiation MedicineMedical ImagingRadiation TherapyInoperable Early Stage	2013	159
Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study Luca Triggiani, Filippo Alongi, Michela Buglione, British Journal of Cancer	2017	147
IMRT significantly reduces acute toxicity of whole-pelvis irradiation in patients treated with post-operative adjuvant or salvage radiotherapy after radical prostatectomy Filippo Alongi, C. Fiorino, C. Cozzarini, Radiotherapy and Oncology UrologySurgical OncologyRadiation TherapyMedicineBrachytherapy	2009	144
Metastasis-directed Therapy in Treating Nodal Oligorecurrent Prostate Cancer: A Multi-institutional Analysis Comparing the Outcome and Toxicity of Stereotactic Body Radiotherapy and Elective Nodal Radiotherapy Elise De Bleser, Barbara Alicja Jereczek‐Fossa, Thomas Zilli, European Urology Surgical OncologyUrologyRadiation TherapyMetastasis-directed TherapyMedicine	2019	137
1.5 T MR-guided and daily adapted SBRT for prostate cancer: feasibility, preliminary clinical tolerability, quality of life and patient-reported outcomes during treatment Filippo Alongi, Michele Rigo, Vanessa Figlia, Radiation Oncology	2020	132
Feasibility and early clinical assessment of flattening filter free (FFF) based stereotactic body radiotherapy (SBRT) treatments Marta Scorsetti, Filippo Alongi, Simona Castiglioni, Radiation Oncology	2011	120
Linac based SBRT for prostate cancer in 5 fractions with VMAT and flattening filter free beams: preliminary report of a phase II study Filippo Alongi, Luca Cozzi, Stefano Arcangeli, Radiation Oncology	2013	105

Page 1